OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 63 filers reported holding OVID THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,376,361 | -73.8% | 3,089,393 | +3.8% | 0.00% | – |
| Q1 2024 | $9,077,740 | -5.7% | 2,976,308 | -0.5% | 0.00% | – |
| Q4 2023 | $9,627,083 | -15.5% | 2,989,777 | +0.8% | 0.00% | – |
| Q3 2023 | $11,391,042 | +19.8% | 2,966,417 | +2.3% | 0.00% | – |
| Q2 2023 | $9,509,468 | +41.2% | 2,899,228 | +11.1% | 0.00% | – |
| Q1 2023 | $6,735,354 | +40.3% | 2,610,602 | +1.1% | 0.00% | – |
| Q4 2022 | $4,802,029 | +1.1% | 2,581,736 | +0.0% | 0.00% | – |
| Q3 2022 | $4,748,000 | -12.9% | 2,580,590 | +1.8% | 0.00% | – |
| Q2 2022 | $5,450,000 | -52.9% | 2,535,090 | -31.3% | 0.00% | – |
| Q1 2022 | $11,580,000 | +4.8% | 3,687,909 | +7.1% | 0.00% | – |
| Q4 2021 | $11,051,000 | -2.8% | 3,442,618 | +1.8% | 0.00% | – |
| Q3 2021 | $11,364,000 | -17.1% | 3,382,081 | -3.5% | 0.00% | – |
| Q2 2021 | $13,706,000 | -2.5% | 3,505,637 | +0.3% | 0.00% | – |
| Q1 2021 | $14,056,000 | +95.9% | 3,496,386 | +12.6% | 0.00% | – |
| Q4 2020 | $7,174,000 | -51.9% | 3,105,752 | +19.6% | 0.00% | – |
| Q3 2020 | $14,903,000 | -4.7% | 2,596,335 | +22.4% | 0.00% | -100.0% |
| Q2 2020 | $15,636,000 | +208.8% | 2,121,632 | +24.9% | 0.00% | – |
| Q1 2020 | $5,064,000 | -18.0% | 1,698,971 | +14.1% | 0.00% | – |
| Q4 2019 | $6,177,000 | +79.1% | 1,488,529 | +39.8% | 0.00% | – |
| Q3 2019 | $3,449,000 | +69.9% | 1,064,568 | -3.0% | 0.00% | – |
| Q2 2019 | $2,030,000 | +75.3% | 1,097,614 | +67.8% | 0.00% | – |
| Q1 2019 | $1,158,000 | +63.6% | 654,124 | +123.8% | 0.00% | – |
| Q4 2018 | $708,000 | -72.0% | 292,260 | -34.6% | 0.00% | – |
| Q3 2018 | $2,533,000 | -27.0% | 446,770 | +0.5% | 0.00% | – |
| Q2 2018 | $3,469,000 | +22.5% | 444,767 | +11.0% | 0.00% | – |
| Q1 2018 | $2,832,000 | -14.1% | 400,530 | +19.9% | 0.00% | – |
| Q4 2017 | $3,298,000 | +138.1% | 334,066 | +106.7% | 0.00% | – |
| Q3 2017 | $1,385,000 | +32.9% | 161,657 | +62.8% | 0.00% | – |
| Q2 2017 | $1,042,000 | – | 99,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,540,671 | $2,835,000 | 1.27% |
| Madison Avenue Partners, LP | 1,394,022 | $2,565,000 | 0.55% |
| BVF INC/IL | 6,851,051 | $12,606,000 | 0.52% |
| CHI Advisors LLC | 864,822 | $1,591,000 | 0.43% |
| Rubric Capital Management LP | 4,516,300 | $8,310,000 | 0.42% |
| EcoR1 Capital, LLC | 6,117,400 | $11,256,000 | 0.33% |
| Artal Group S.A. | 2,500,000 | $4,600,000 | 0.20% |
| DCF Advisers, LLC | 162,701 | $299,000 | 0.19% |
| Oasis Management Co Ltd. | 270,000 | $497,000 | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 908,500 | $1,672,000 | 0.04% |